New York Bride Who Faked Leukemia Faces the Music

One of the most reviled people in the cancer world finally learned her punishment this week after a New York state judge handed down a sentence to Jessica Vega, the young NY woman who faked a fatal diagnosis of leukemia in 2010 in order to pay for an extravagant wedding and honeymoon.

Vega began scamming family, friends, and local retailers in January 2010, informing them that she had been diagnosed with terminal leukemia and had just months to live. She received an outpouring of support from her community, totaling over $13,000 in cash and gifts.

She maintained the lie for almost six months, until she and her fiance enjoyed a 'dream wedding' followed by a honeymoon on the island of Aruba.

Shortly after she returned, her story began to fall apart, and eventually she was charged with fraud and grand larceny.

She would spend eight weeks in an Orange County jail, until Judge Robert Freehill ordered her to return the $13,368.48 she stole under the pretense of being sick and dying from leukemia. He also gave her 300 hours of community service to go with five years of probation.

Remarkably, not only is her husband not named in the indictment, authorities believe he was not involved in the scam, and he has not been charged with any criminal wrongdoing.

Source: CNN

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap